- All sections
- C - Chemistry; metallurgy
- C07K - Peptides
- C07K 14/72 - Receptors; Cell surface antigens; Cell surface determinants for hormones
Patent holdings for IPC class C07K 14/72
Total number of patents in this class: 881
10-year publication summary
|
50
|
53
|
79
|
77
|
93
|
79
|
70
|
77
|
64
|
15
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1144 |
38 |
| Heptares Therapeutics Limited | 225 |
23 |
| The Regents of the University of California | 18943 |
19 |
| Vib VZW | 799 |
18 |
| Vrije Universiteit Brussel | 482 |
18 |
| The Board of Trustees of the Leland Stanford Junior University | 6054 |
14 |
| Regeneron Pharmaceuticals, Inc. | 3650 |
14 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 1906 |
12 |
| Hanmi Pharm. Co., Ltd. | 546 |
10 |
| Cornell University | 3036 |
9 |
| Amgen Inc. | 3779 |
8 |
| Massachusetts Institute of Technology | 9795 |
8 |
| Asterion Limited | 24 |
8 |
| Rhythm Pharmaceuticals, Inc. | 63 |
8 |
| H. Lundbeck A/S | 1252 |
8 |
| The Johns Hopkins University | 5377 |
7 |
| President and Fellows of Harvard College | 5792 |
7 |
| Duke University | 2872 |
7 |
| Mereo Biopharma 5, Inc. | 60 |
7 |
| Board of Regents, The University of Texas System | 5370 |
6 |
| Other owners | 632 |